Gemcitabine radiosensitization primes irradiated malignant meningioma cells for senolytic elimination by navitoclax

BACKGROUND: Malignant meningioma is an aggressive tumor that requires adjuvant radiotherapy after surgery, yet there has been no standard systemic therapy established so far. We recently reported that malignant meningioma cells are highly sensitive to gemcitabine; however, it remains unknown whether...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamamoto, Masahiro, Sanomachi, Tomomi, Suzuki, Shuhei, Togashi, Keita, Sugai, Asuka, Seino, Shizuka, Sato, Atsushi, Okada, Masashi, Kitanaka, Chifumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Basic and Translational Investigations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577526/
https://www.ncbi.nlm.nih.gov/pubmed/34765973
http://dx.doi.org/10.1093/noajnl/vdab148

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577526/
https://www.ncbi.nlm.nih.gov/pubmed/34765973
http://dx.doi.org/10.1093/noajnl/vdab148

Ejemplares similares